Primary Cicatricial Alopecias: Clinicopathology of 112 Cases

    Eileen Tan, Magdalena Martinka, Nigel J. Ball, Jerry Shapiro
    TLDR Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.
    The study reviewed 112 cases of primary cicatricial alopecias over 5 years at the University of British Columbia Hair Clinic, representing 3.2% of consultations. It found a 4:1 ratio of lymphocytic to neutrophilic cicatricial alopecias, with lymphocytic types more common in middle-aged women and neutrophilic types in middle-aged men. Accurate diagnosis required careful clinicopathologic evaluation, often necessitating multiple scalp biopsies due to the variable clinical course. The study emphasized the need for aggressive, multi-modal treatment to prevent irreversible follicular destruction, suggesting cicatricial alopecia should be treated as a trichologic emergency. Treatment options included corticosteroids, antimalarials, and isotretinoin for lymphocytic types, and antibiotics, corticosteroids, and isotretinoin for neutrophilic types.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 282 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  121 upvotes 5 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    1 / 1 results